These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 8642257)
21. A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7. Wu Y; Guo Y; Liu Y J Exp Med; 1993 Nov; 178(5):1789-93. PubMed ID: 8228824 [TBL] [Abstract][Full Text] [Related]
22. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Gimmi CD; Freeman GJ; Gribben JG; Sugita K; Freedman AS; Morimoto C; Nadler LM Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6575-9. PubMed ID: 1650475 [TBL] [Abstract][Full Text] [Related]
23. The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant. Liu X; Wetzler LM; Massari P Vaccine; 2008 Feb; 26(6):786-96. PubMed ID: 18191311 [TBL] [Abstract][Full Text] [Related]
24. Signaling by a new anti-Thy 1 monoclonal antibody inhibits T cell proliferation and interferes with T-cell-mediated induction of costimulatory molecule B7-2. Wu Y; Guo Y; Janeway CA; Liu Y Cell Immunol; 1995 Oct; 165(2):266-77. PubMed ID: 7553891 [TBL] [Abstract][Full Text] [Related]
25. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Boussiotis VA; Freeman GJ; Gribben JG; Daley J; Gray G; Nadler LM Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11059-63. PubMed ID: 7504293 [TBL] [Abstract][Full Text] [Related]
26. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. Mitra RS; Judge TA; Nestle FO; Turka LA; Nickoloff BJ J Immunol; 1995 Mar; 154(6):2668-77. PubMed ID: 7533180 [TBL] [Abstract][Full Text] [Related]
27. Neisserial porins inhibit human neutrophil actin polymerization, degranulation, opsonin receptor expression, and phagocytosis but prime the neutrophils to increase their oxidative burst. Bjerknes R; Guttormsen HK; Solberg CO; Wetzler LM Infect Immun; 1995 Jan; 63(1):160-7. PubMed ID: 7806353 [TBL] [Abstract][Full Text] [Related]
28. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors. Greenfield EA; Howard E; Paradis T; Nguyen K; Benazzo F; McLean P; Höllsberg P; Davis G; Hafler DA; Sharpe AH; Freeman GJ; Kuchroo VK J Immunol; 1997 Mar; 158(5):2025-34. PubMed ID: 9036945 [TBL] [Abstract][Full Text] [Related]
29. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Chaux P; Moutet M; Faivre J; Martin F; Martin M Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792 [TBL] [Abstract][Full Text] [Related]
30. Prevention of primary T-cell responses by immunotoxins directed against CD80 and CD86. Otten HG; Vooijs WC; van der Gouw AP; de Boer M; de Gast GC Transplant Proc; 1997; 29(1-2):1034-5. PubMed ID: 9123185 [No Abstract] [Full Text] [Related]
31. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. Behrens L; Kerschensteiner M; Misgeld T; Goebels N; Wekerle H; Hohlfeld R J Immunol; 1998 Dec; 161(11):5943-51. PubMed ID: 9834075 [TBL] [Abstract][Full Text] [Related]
32. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice. Weintraub JP; Eisenberg RA; Cohen PL J Immunol; 1997 Oct; 159(8):4117-26. PubMed ID: 9379003 [TBL] [Abstract][Full Text] [Related]
33. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411 [TBL] [Abstract][Full Text] [Related]
34. Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Prabhu Das MR; Zamvil SS; Borriello F; Weiner HL; Sharpe AH; Kuchroo VK Eur J Immunol; 1995 Jan; 25(1):207-11. PubMed ID: 7531145 [TBL] [Abstract][Full Text] [Related]
35. Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma. Tatsumi T; Takehara T; Katayama K; Mochizuki K; Yamamoto M; Kanto T; Sasaki Y; Kasahara A; Hayashi N Hepatology; 1997 May; 25(5):1108-14. PubMed ID: 9141426 [TBL] [Abstract][Full Text] [Related]
36. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679 [TBL] [Abstract][Full Text] [Related]
37. Differential effect of anti-B7-1 and anti-M150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages. Agrewala JN; Suvas S; Verma RK; Mishra GC J Immunol; 1998 Feb; 160(3):1067-77. PubMed ID: 9570518 [TBL] [Abstract][Full Text] [Related]
38. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition. Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189 [TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody 2D10 recognizes a novel T cell costimulatory molecule on activated murine B lymphocytes. Chen C; Faherty DA; Gault A; Connaughton SE; Powers GD; Godfrey DI; Nabavi N J Immunol; 1994 Mar; 152(5):2105-14. PubMed ID: 7510738 [TBL] [Abstract][Full Text] [Related]
40. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection. Elloso MM; Scott P J Immunol; 1999 Jun; 162(11):6708-15. PubMed ID: 10352289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]